Abstract
A new hybrid compound has been synthesized by the covalent grafting of (Bu4N)5H4[P2W15Nb3O62] to folic acid and used selectively against human breast (MCF-7) and cervical (HeLa) cancer cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
